Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated 11 minutes ago
AstraZeneca pens agentic AI licensing deal with Owkin
11 minutes ago
AstraZeneca is the latest Big Pharma company looking to tap into agentic...
Kyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis
about 10 hours ago
Kyverna Therapeutics has officially started a rolling submission to the FDA for...
FDA Commissioner Marty Makary to resign, capping turbulent tenure: report
about 10 hours ago
Marty Makary, M.D., is resigning as FDA commissioner Tuesday, ending a brief...
Charles River debuts AI diagnostic tool to cut down pathology timelines
about 13 hours ago
Charles River is rolling out an artificial intelligence-backed digital pathology platform with...
Alphabet's AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model
about 15 hours ago
If any proof was needed that big money is still available for...
Boehringer furthers inflammatory expansion with €407M biobucks bet on Immunitas asset
about 16 hours ago
Boehringer Ingelheim has put up 407.5 million euros in biobucks to secure...
AstraZeneca’s $800M bet undermined by immunogenicity in phase 3
about 17 hours ago
Immunogenicity dragged on the efficacy of AstraZeneca’s rare endocrine disorder prospect in...
Roche nabs European approval for second Eli Lilly-partnered Alzheimer’s test
about 19 hours ago
Roche has secured a European CE mark for its second Alzheimer’s test...
Bayer scraps protein therapy for hypertension from phase 1, along with neuropathic pain drug
about 20 hours ago
Bayer has removed a protein therapeutic for hypertension and a treatment for...
Blood-based approach could detect early heart, kidney disease, study finds
about 21 hours ago
Scientists know that damage to microscopic blood vessels can provide an early...
Enterprise reports phase 2 cystic fibrosis win, succeeding where Big Pharma stumbled
about 22 hours ago
A phase 2 trial of Enterprise Therapeutics’ cystic fibrosis drug candidate has...
Bristol Myers Squibb inks $15B biobucks deal to bag Hengrui assets, tap China’s R&D speed
1 day ago
Bristol Myers Squibb has formed a broad partnership with Hengrui Pharma, paying...